Zacks Small Cap Analysis – TELO Produces Outcomes with Thrilling AMD Implications – Model Slux
By Brad Sorensen, CFA NASDAQ:TELO READ THE FULL TELO RESEARCH REPORT Telomir Prescribed drugs (NASDAQ:TELO) is a preclinical stage biopharmaceutical firm creating a product designed to elongate the DNA’s protecting telomere caps. Beforehand reported preclinical checks have proven proof that Telomir-1, the corporate’s main remedy, can lengthen telomeres and preliminary animal testing illustrates the potential … Read more
